These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 29676340)
1. Progesterone receptor expression and Ki-67 labelling index of meningiomas in the Lagos university teaching hospital. Ikeri NZ; Anunobi CC; Bankole OB Niger Postgrad Med J; 2018; 25(1):17-20. PubMed ID: 29676340 [TBL] [Abstract][Full Text] [Related]
2. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas. Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191 [TBL] [Abstract][Full Text] [Related]
3. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma. Shayanfar N; Mashayekh M; Mohammadpour M Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648 [TBL] [Abstract][Full Text] [Related]
4. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection. Mizrachi M; Hartley B; Saleem S; Hintz E; Ziemba Y; Li J; Goenka A; Schulder M J Clin Neurosci; 2024 Jun; 124():15-19. PubMed ID: 38631196 [TBL] [Abstract][Full Text] [Related]
5. Association of apparent diffusion coefficient with Ki-67 proliferation index, progesterone-receptor status and various histopathological parameters, and its utility in predicting the high grade in meningiomas. Bozdağ M; Er A; Ekmekçi S Acta Radiol; 2021 Mar; 62(3):401-413. PubMed ID: 32397733 [TBL] [Abstract][Full Text] [Related]
6. Proliferation and progesterone receptor status in benign meningiomas are not age dependent. Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201 [TBL] [Abstract][Full Text] [Related]
7. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature. Wolfsberger S; Doostkam S; Boecher-Schwarz HG; Roessler K; van Trotsenburg M; Hainfellner JA; Knosp E Neurosurg Rev; 2004 Oct; 27(4):238-45. PubMed ID: 15168138 [TBL] [Abstract][Full Text] [Related]
8. Is progesteron receptor status really a prognostic factor for intracranial meningiomas? Iplikcioglu AC; Hatiboglu MA; Ozek E; Ozcan D Clin Neurol Neurosurg; 2014 Sep; 124():119-22. PubMed ID: 25036873 [TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of MMP-9, PR, Ki-67 and Survivin in multiple meningiomas]. Gong J; Zhu SG; Wu CY; Li XG; Liu YG; Ren XH; Zhang Y Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(45):3218-20. PubMed ID: 23328471 [TBL] [Abstract][Full Text] [Related]
10. Status of Ki-67, estrogen and progesterone receptors in various subtypes of intracranial meningiomas. Fakhrjou A; Meshkini A; Shadrvan S Pak J Biol Sci; 2012 Jun; 15(11):530-5. PubMed ID: 24191627 [TBL] [Abstract][Full Text] [Related]
11. Clinical features and immunohistochemical expression levels of androgen, estrogen, progesterone and Ki-67 receptors in relationship with gross-total resected meningiomas relapse. Tao Y; Liang G; Li Z; Wang Y; Wu A; Wang H; Lu Y; Liu Z; Hu G Br J Neurosurg; 2012 Oct; 26(5):700-4. PubMed ID: 22616825 [TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in anterior skull base meningiomas. Ciocan LM; Dănăilă L; Stănculescu DE; Neamţu SD; Mateescu GO; Stanca L Rom J Morphol Embryol; 2014; 55(3 Suppl):1063-9. PubMed ID: 25607386 [TBL] [Abstract][Full Text] [Related]
13. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors. Maiuri F; De Caro MB; Esposito F; Cappabianca P; Strazzullo V; Pettinato G; de Divitiis E J Neurooncol; 2007 Mar; 82(1):63-8. PubMed ID: 17225937 [TBL] [Abstract][Full Text] [Related]
14. WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma. Maiuri F; Mariniello G; Guadagno E; Barbato M; Corvino S; Del Basso De Caro M Acta Neurochir (Wien); 2019 Dec; 161(12):2553-2561. PubMed ID: 31637512 [TBL] [Abstract][Full Text] [Related]
16. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453 [TBL] [Abstract][Full Text] [Related]
17. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Roser F; Samii M; Ostertag H; Bellinzona M Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263 [TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas. Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792 [TBL] [Abstract][Full Text] [Related]
19. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study]. Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760 [TBL] [Abstract][Full Text] [Related]
20. Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma. Tang Y; Dundamadappa SK; Thangasamy S; Flood T; Moser R; Smith T; Cauley K; Takhtani D AJR Am J Roentgenol; 2014 Jun; 202(6):1303-8. PubMed ID: 24848829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]